Screened 2026-08-27 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
SharonAI Holdings Inc. holds its Markdown at $59.21. Consolidating, no directional conviction, held for 4 days.
As held on the ledger · 2026-08-27
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 4 days
Price at the screen
$59.21
Valuation
N/A trailing · -7.79 forward price to earnings
Values screen
FAIL· score 70.0
Beta
6.21
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
102.35%
Below 33%
Interest-bearing debt is 102.3% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
53.42%
Below 49%
Money owed to the company is 53.4% of assets, above the 49% limit.
Fail
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. A 87.5% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +87% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
AI Hype Cannot Paper Over Losses
Picture a data centre packed with the latest GPUs yet burning cash faster than it can sign contracts. SharonAI sits in that spot, with revenue shrinking 10 percent, zero profit margins and return on equity at minus 99 percent. The market may cheer a $113 target but the published figures show a business still far from turning a corner.
We pass for the simple reason that no margin of safety exists when growth is negative and every dollar of equity is being destroyed. Strong analyst ratings and an ethical pass do not change the fact that current operations produce no returns and forward earnings sit deep in the red at minus 27.9 times.
The real risk is that continued losses force repeated capital raises, diluting holders while the hybrid data-centre model stays unproven at scale. Cyclical demand swings in AI infrastructure could widen those shortfalls quickly. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SHAZ trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-12Markdown · changed$59.21-7.0%Entry 5
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (3 analysts) rates it strong buy, with a mean price target of $78.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (3 analysts) rates it strong buy, with a mean price target of $78.
2026-07-18Markup$62.32+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (3 analysts) rates it strong buy, with a mean price target of $78.
2026-07-03Markup$62.32+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$62.32Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.